Reynolds Capital Management’s Pfizer PFE Stock Holding History

Reynolds Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$379K	Sell	13,491 -13,544	-50%	-$387K	0.66%	42
2015 Q4	$828K	Buy	27,035 +1,686	+7%	+$53K	0.9%	26
2015 Q3	$755K	Buy	25,349 +8,748	+53%	+$280K	0.95%	27
2015 Q2	$528K	Sell	16,601 -316	-2%	-$10.3K	0.52%	54
2015 Q1	$558K	Sell	16,917 -948	-5%	-$30.1K	0.49%	55
2014 Q4	$528K	Buy	17,865 +5,375	+43%	+$154K	0.44%	69
2014 Q3	$350K	Sell	12,490 -843	-6%	-$23.7K	0.34%	105
2014 Q2	$375K	Hold	13,333	–	–	0.25%	150
2014 Q1	$406K	Buy	13,333 +2,002	+18%	+$59.7K	0.26%	134
2013 Q4	$329K	Buy	+11,331	New	+$330K	0.18%	215
2013 Q3	–	Sell	-20,922	Closed	-$556K	–	452
2013 Q2	$556K	Buy	+20,922	New	+$578K	0.41%	54

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Reynolds Capital Management's PFE Position: Q1 2016 in Review

Reynolds Capital Management reduced its Pfizer (PFE) stake by 50% in Q1 2016, selling an estimated $387K and leaving 13,491 shares worth $379K. The position accounts for 0.66% of the portfolio, ranked #42.

Reynolds Capital Management first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $828K in Q4 2015. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Reynolds Capital Management held 13,491 shares of Pfizer worth $379K as of Q1 2016.
Reynolds Capital Management sold 13,544 Pfizer shares in Q1 2016, an estimated $387K.
Pfizer made up 0.66% of Reynolds Capital Management's portfolio in Q1 2016, its #42 holding.
Reynolds Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
Reynolds Capital Management's Pfizer position peaked at $828K in Q4 2015.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.